SDCCQ vs. BIOL, IONM, GMVDF, VRAYQ, AHPI, NMRD, VIVE, BRSH, UTRS, and MOTS
Should you be buying SmileDirectClub stock or one of its competitors? The main competitors of SmileDirectClub include BIOLASE (BIOL), Assure (IONM), G Medical Innovations (GMVDF), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Viveve Medical (VIVE), Bruush Oral Care (BRSH), Minerva Surgical (UTRS), and Motus GI (MOTS). These companies are all part of the "medical equipment" industry.
SmileDirectClub vs.
BIOLASE (NASDAQ:BIOL) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership.
SmileDirectClub has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. SmileDirectClub's return on equity of 0.00% beat BIOLASE's return on equity.
BIOLASE currently has a consensus price target of $1.20, indicating a potential upside of 13,383.15%. Given BIOLASE's stronger consensus rating and higher possible upside, research analysts clearly believe BIOLASE is more favorable than SmileDirectClub.
In the previous week, BIOLASE and BIOLASE both had 1 articles in the media. BIOLASE's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.
8.8% of BIOLASE shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 0.3% of BIOLASE shares are owned by company insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
BIOLASE received 292 more outperform votes than SmileDirectClub when rated by MarketBeat users.
BIOLASE has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, SmileDirectClub has a beta of 1.87, meaning that its share price is 87% more volatile than the S&P 500.
BIOLASE has higher earnings, but lower revenue than SmileDirectClub.
Summary
BIOLASE beats SmileDirectClub on 7 of the 13 factors compared between the two stocks.
Get SmileDirectClub News Delivered to You Automatically
Sign up to receive the latest news and ratings for SDCCQ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SDCCQ vs. The Competition
SmileDirectClub Competitors List
Related Companies and Tools
This page (NASDAQ:SDCCQ) was last updated on 1/21/2025 by MarketBeat.com Staff
